Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 136 to 150 of 159 results for surgical site infections

  1. Complicated intra-abdominal infections: ceftolozane/tazobactam (ESNM75)

    Summary of the evidence on ceftolozane/tazobactam for treating complicated intra-abdominal infections to inform local NHS planning and decision-making

  2. Teduglutide for treating short bowel syndrome (TA804)

    Evidence-based recommendations on teduglutide (Resvestive) for treating short bowel syndrome in people 1 year and above.

  3. BD MAX Enteric Bacterial Panel for identifying pathogens in contagious gastroenteritis (MIB32)

    NICE has developed a medtech innovation briefing (MIB) on BD MAX Enteric Bacterial Panel for identifying pathogens in contagious gastroenteritis .

  4. Memokath 051 Ureter stent for ureteric obstruction (HTG651)

    Evidence-based recommendations on Memokath 051 Ureter stent for ureteric obstruction.

  5. Which closure method or technique is the most effective for reducing surgical site infections in patients undergoing emergency surgery?

    closure method or technique is the most effective for reducing surgical site infections in patients undergoing emergency surgery? Any...

  6. What is the effectiveness of decolonisation using alternative interventions in combination with nasal decolonisation in the prevention of surgical site infections when chlorhexidine is contraindicated?

    interventions in combination with nasal decolonisation in the prevention of surgical site infections when chlorhexidine is...

  7. EpiFix for chronic wounds (MIB139)

    NICE has developed a medtech innovation briefing (MIB) on EpiFix for chronic wounds .

  8. Surgical site infections: prevention and treatment - Update

    Discontinued Reference number: GID-NG10374

  9. Surgical site infections: prevention and treatment (CG74)

    This guidance has been updated and replaced by NICE guideline NG125.

  10. Leukomed Sorbact for preventing surgical site infection (MTG55)

    We have moved Medical technologies guidance 55 to become HealthTech guidance 567. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  11. Plus Sutures for preventing surgical site infection (MTG59)

    We have moved Medical technologies guidance 59 to become HealthTech guidance 586. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  12. Leukomed Sorbact for preventing surgical site infection (MIB197)

    This advice has been updated and replaced by NICE healthtech guidance 567.

  13. Plus Sutures for preventing surgical site infection (MIB204)

    This advice has been updated and replaced by NICE healthtech guidance guidance 586.

  14. What is the clinical effectiveness of preoperative nasal decolonisation using mupirocin in combination with a chlorhexidine body wash in the whole population?

    Source guidance details Comes from guidance Surgical site infections: prevention and treatment Number NG125 Date issued

  15. What is the clinical and cost effectiveness of a double application of antiseptic to the skin at the surgical site compared with a single application?

    effectiveness of a double application of antiseptic to the skin at the surgical site compared with a single application?...